Literature DB >> 30706377

Neuroendocrine Tumors in Meckel's Diverticulum: Recommendation for Lymphadenectomy Regardless of Tumor Size Based on the NCDB Experience.

Epameinondas Dogeas1, Maximiliano Magallanes1, Matthew R Porembka1, Sam C Wang1, Adam C Yopp1, Patricio M Polanco1, John C Mansour1, Michael A Choti2, Herbert J Zeh1, Mathew M Augustine3.   

Abstract

BACKGROUND: Meckel's diverticulum (MD) is an anomaly of the small intestine from which malignancy may arise. Among MD neoplasms, neuroendocrine tumors (NETs) are considered the most common. However, their metastatic potential and optimal surgical therapy remain ill-defined.
METHODS: In a retrospective analysis of the National Cancer Database (2004-2015), patients with a diagnosis of MD malignancy were identified. Clinicopathologic factors were extracted and tumors arising in MD were compared. In the subgroup of patients with NET, the association between tumor factors and node involvement was investigated.
RESULTS: Three hundred twenty primary MD malignancies were captured in the National Cancer Database, consisting of 280 (87.5%) NET. The median age at diagnosis was 64 years. Patients were predominantly male (207, 73.9%) and white (269, 96.1%). Most tumors were well-differentiated (118, 42.1%) and sub-centimeter (median size, 0.7 cm). Distant metastasis was present in a minority (16, 5.7%), and the median overall survival was 114 months in the entire cohort. The regional lymph node status was known in 87 NET patients, out of which 39 (44.8%) harbored node metastasis. Although the risk of node involvement increased with larger tumor size, it remained significant even among sub-centimeter (9 out of 34, 26.5%) and well-differentiated (18 out of 44, 41%) tumors. Regional node involvement was associated with the presence of distant metastasis (p < 0.001).
CONCLUSION: Lymph node involvement was common irrespective of the size and grade of NET arising from Meckel's diverticulum. Therefore, regional lymphadenectomy should be considered in the curative-intent surgical management of these neoplasms regardless of tumor size and grade.

Entities:  

Keywords:  Carcinoid; Lymph nodes; Lymphadenectomy; Meckel’s diverticulum; Neuroendocrine tumors; Small bowel; Small intestine

Mesh:

Year:  2019        PMID: 30706377     DOI: 10.1007/s11605-018-04096-7

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  9 in total

Review 1.  Incidentally detected Meckel diverticulum: to resect or not to resect?

Authors:  Augusto Zani; Simon Eaton; Clare M Rees; Agostino Pierro
Journal:  Ann Surg       Date:  2008-02       Impact factor: 12.969

Review 2.  Meckel's diverticulum in the adult.

Authors:  J Lequet; B Menahem; A Alves; A Fohlen; A Mulliri
Journal:  J Visc Surg       Date:  2017-07-09       Impact factor: 2.043

Review 3.  Medical Management of Pancreatic Neuroendocrine Tumors: Current and Future Therapy.

Authors:  Jennifer A Chan; Matthew H Kulke
Journal:  Surg Oncol Clin N Am       Date:  2016-02-19       Impact factor: 3.495

4.  Optimal Lymphadenectomy in Small Bowel Neuroendocrine Tumors: Analysis of the NCDB.

Authors:  Benjamin M Motz; Patrick D Lorimer; Danielle Boselli; Joshua S Hill; Jonathan C Salo
Journal:  J Gastrointest Surg       Date:  2017-08-17       Impact factor: 3.452

5.  Meckel's diverticulum--a high-risk region for malignancy in the ileum. Insights from a population-based epidemiological study and implications in surgical management.

Authors:  Pragatheeshwar Thirunavukarasu; Magesh Sathaiah; Shyam Sukumar; Christopher J Bartels; Herbert Zeh; Kenneth K W Lee; David L Bartlett
Journal:  Ann Surg       Date:  2011-02       Impact factor: 12.969

Review 6.  Carcinoid tumor in Meckel's diverticulum: laparoscopic treatment and review of the literature.

Authors:  D J Anderson
Journal:  J Am Osteopath Assoc       Date:  2000-07

7.  Neuroendocrine tumors of Meckel's diverticulum: lessons from a single institution study of eight cases.

Authors:  Gilles Poncet; Valérie Hervieu; Thomas Walter; Florian Lépinasse; Laurence Chardon; Frank Pilleul; Catherine Lombard-Bohas; Jean-Alain Chayvialle; Christian Partensky; Jean-Yves Scoazec
Journal:  J Gastrointest Surg       Date:  2010-09-08       Impact factor: 3.452

8.  Neuroendocrine tumors arising in Meckel's diverticula: frequency of advanced disease warrants aggressive management.

Authors:  Allison W Lorenzen; Thomas M O'Dorisio; James R Howe
Journal:  J Gastrointest Surg       Date:  2013-04-05       Impact factor: 3.452

9.  Exploration of the Exact Prognostic Significance of Lymphatic Metastasis in Jejunoileal Neuroendocrine Tumors.

Authors:  Luohai Chen; Yunda Song; Yu Zhang; Minhu Chen; Jie Chen
Journal:  Ann Surg Oncol       Date:  2018-05-10       Impact factor: 5.344

  9 in total
  3 in total

1.  Meckel's Diverticulum Diagnosed by Balloon-Assisted Enteroscopy: A Multicenter Report from the Taiwan Association for the Study of Small Intestinal Diseases (TASSID).

Authors:  Jen-Wei Chou; Chen-Shuan Chung; Tien-Yu Huang; Chia-Hung Tu; Chen-Wang Chang; Chung-Hsin Chang; Yen-Po Wang; Wen-Hung Hsu; Hsu-Heng Yen; Chia-Jung Kuo; Chiao-Hsiung Chuang; Ching-Pin Lin; Tzung-Jiun Tsai; Ming-Yao Su; Horng-Yuan Wang; Deng-Chyang Wu; Cheng-Tang Chiu
Journal:  Gastroenterol Res Pract       Date:  2021-11-18       Impact factor: 2.260

2.  Incidental Meckel's Diverticulum With Neuroendocrine Tumor.

Authors:  Clarissa K Chan; Tiffany Pham; Yash V Bhagat; William Fulton; Majid Kianmajd
Journal:  Cureus       Date:  2022-08-02

3.  Role of Removed Lymph Nodes on the Prognosis of M0 Small-Bowel Neuroendocrine Tumors: a Propensity Score Matching Analysis from SEER Database.

Authors:  Jie-Bin Xie; Yue-Shan Pang; Xun Li; Xiao-Ting Wu
Journal:  J Gastrointest Surg       Date:  2021-06-09       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.